JD Health InternationalFRA:8ZN +1.61%90 OCF Yield % is 10.56 as of Jun. 25, 2026, which is 195% above its 10-year median of 3.58. GuruFocus rates FRA:8ZN with a GF Score™ of 90/100 and a GF Value™ of €6.38 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 685 Healthcare Providers & Services companies, JD Health International ranks better than 70.22% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for JD Health International's OCF Yield % or its related term are showing as below:
FRA:8ZN'
s OCF Yield % Range Over the Past 10 Years
Min: 0.09 Med: 3.58 Max: 10.56
Current: 10.56
During the past 9 years, the highest OCF Yield % of JD Health International was 10.56%. The lowest was 0.09%. And the median was 3.58%.
FRA:8ZN's OCF Yield % is ranked better than 70.22% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 5.55
vs FRA:8ZN: 10.56
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
JD Health International OCF Yield % Related Terms
JD Health International OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International OCF Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's OCF Yield % distribution charts can be found below:
* The bar in red indicates where JD Health International's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (FRA:8ZN) has a OCF Yield % of 10.56 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on JD Health International and its competitors. This is 195% above median its historical median of 3.58. Over the past decade, JD Health International's OCF Yield % has ranged from 0.09 to 10.56. According to the industry distribution chart, JD Health International ranks #204 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 29.8%.
Is JD Health International's OCF Yield % too high?
JD Health International's current OCF Yield % of 10.56 is 195% above median its 10-year median of 3.58. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 10.56. The Healthcare Providers & Services industry median OCF Yield % is 5.55. JD Health International's value of 10.56 is 90.3% above this industry median. Based on the distribution chart, JD Health International ranks #204 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JD Health International's OCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #204 out of 685 companies for OCF Yield %. This puts JD Health International in the upper half of its industry. The industry median OCF Yield % is 5.55. JD Health International's value of 10.56 is 90.3% above this benchmark. Historically, JD Health International's own OCF Yield % has ranged from 0.09 to 10.56 over the past decade. While the company's 10-year median is 3.58 vs. the industry median of 5.55, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.55, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current OCF Yield % of 10.56 is 90.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current OCF Yield % is 10.56, which is 195% above median its own 10-year median of 3.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
Based on GuruFocus' analysis, JD Health International (FRA:8ZN) is currently considered Significantly Undervalued. The stock's GF Value™ is €6.38, compared to a current price of €3.72 — trading 41.7% below its estimated fair value. The current OCF Yield % is 10.56, which is 195% above median its 10-year median of 3.58 and 90.3% above the Healthcare Providers & Services industry median of 5.55. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For JD Health International (FRA:8ZN), the current OCF Yield % is 10.56 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (FRA:8ZN) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of €3.72 is trading 41.7% below its estimated GF Value™ of €6.38.
GuruFocus considers JD Health International to be Significantly Undervalued.
Key valuation signals for FRA:8ZN:
OCF Yield %: 10.56 (195% above median its 10-year median of 3.58)
GF Value™: €6.38 vs. price of €3.72 (41.7% below fair value)
Industry Position: 90.3% above the Healthcare Providers & Services median (#204 of 685)
No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for FRA:8ZN
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8ZN has been successfully added to your 
